Lyric acquires Concert
The healthcare technology company converts clinical policies into machine-readable decisions used in payment-accuracy workflows.
Takeaways
- Concert is a Healthcare payment-accuracy technology company that converts clinical policies into machine-readable decisions.
- Lyric is acquiring Concert with backing from TPG Capital.
- The source materials place the business in United States.
TPG Capital-backed Lyric acquired Concert, a Nashville healthcare technology company focused on precision health payment accuracy.
Concert converts clinical and administrative policies into machine-readable rules that health plans and providers can use in real-time claims decisions.
The companies have worked together since 2023 on an outpatient laboratory testing module, and Concert's technology will now be integrated across the Lyric42 healthcare decision-intelligence platform.
Lyric supports 200 million lives and serves nine of the 10 largest U.S. health plans.
Financial terms were not disclosed.
Get Buyout Desk email updates.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up on the site. Email updates are not on a fixed schedule.